ABCL logo

AbCellera Biologics Inc. (ABCL) Accounts payable

annual accounts payable:

$34.35M+$5.75M(+20.09%)
December 31, 2024

Summary

  • As of today (July 26, 2025), ABCL annual accounts payable is $34.35 million, with the most recent change of +$5.75 million (+20.09%) on December 31, 2024.
  • During the last 3 years, ABCL annual accounts payable has risen by +$19.43 million (+130.17%).
  • ABCL annual accounts payable is now at all-time high.

Performance

ABCL Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLbalance sheet metrics

quarterly accounts payable:

$32.80M-$1.55M(-4.50%)
March 31, 2025

Summary

  • As of today (July 26, 2025), ABCL quarterly accounts payable is $32.80 million, with the most recent change of -$1.55 million (-4.50%) on March 31, 2025.
  • Over the past year, ABCL quarterly accounts payable has increased by +$5.90 million (+21.92%).
  • ABCL quarterly accounts payable is now -5.72% below its all-time high of $34.80 million, reached on September 30, 2024.

Performance

ABCL quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

ABCL Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+20.1%+21.9%
3 y3 years+130.2%+216.9%
5 y5 years+1989.4%-

ABCL Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+131.7%-5.7%+252.0%
5 y5-yearat high+1989.4%-5.7%+815.0%
alltimeall timeat high+2162.6%-5.7%+1895.4%

ABCL Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$32.80M(-4.5%)
Dec 2024
$34.35M(+20.1%)
$34.35M(-1.3%)
Sep 2024
-
$34.80M(+30.9%)
Jun 2024
-
$26.59M(-1.2%)
Mar 2024
-
$26.91M(-5.9%)
Dec 2023
$28.60M(+92.9%)
$28.60M(+64.1%)
Sep 2023
-
$17.43M(-17.1%)
Jun 2023
-
$21.02M(+19.7%)
Mar 2023
-
$17.57M(+18.5%)
Dec 2022
$14.83M
$14.83M(+59.1%)
DateAnnualQuarterly
Sep 2022
-
$9.32M(-9.6%)
Jun 2022
-
$10.31M(-0.4%)
Mar 2022
-
$10.35M(-30.6%)
Dec 2021
$14.92M(+103.9%)
$14.92M(+67.5%)
Sep 2021
-
$8.91M(+58.9%)
Jun 2021
-
$5.61M(+56.3%)
Mar 2021
-
$3.58M(-51.0%)
Dec 2020
$7.32M(+345.3%)
$7.32M(+345.3%)
Dec 2019
$1.64M(+8.3%)
$1.64M
Dec 2018
$1.52M
-

FAQ

  • What is AbCellera Biologics Inc. annual accounts payable?
  • What is the all time high annual accounts payable for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. annual accounts payable year-on-year change?
  • What is AbCellera Biologics Inc. quarterly accounts payable?
  • What is the all time high quarterly accounts payable for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. quarterly accounts payable year-on-year change?

What is AbCellera Biologics Inc. annual accounts payable?

The current annual accounts payable of ABCL is $34.35M

What is the all time high annual accounts payable for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high annual accounts payable is $34.35M

What is AbCellera Biologics Inc. annual accounts payable year-on-year change?

Over the past year, ABCL annual accounts payable has changed by +$5.75M (+20.09%)

What is AbCellera Biologics Inc. quarterly accounts payable?

The current quarterly accounts payable of ABCL is $32.80M

What is the all time high quarterly accounts payable for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high quarterly accounts payable is $34.80M

What is AbCellera Biologics Inc. quarterly accounts payable year-on-year change?

Over the past year, ABCL quarterly accounts payable has changed by +$5.90M (+21.92%)
On this page